1. Home
  2. PT vs RLYB Comparison

PT vs RLYB Comparison

Compare PT & RLYB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PT
  • RLYB
  • Stock Information
  • Founded
  • PT 2012
  • RLYB 2018
  • Country
  • PT China
  • RLYB United States
  • Employees
  • PT N/A
  • RLYB N/A
  • Industry
  • PT Computer Software: Programming Data Processing
  • RLYB Biotechnology: Pharmaceutical Preparations
  • Sector
  • PT Technology
  • RLYB Health Care
  • Exchange
  • PT Nasdaq
  • RLYB Nasdaq
  • Market Cap
  • PT 15.2M
  • RLYB 14.4M
  • IPO Year
  • PT 2018
  • RLYB 2021
  • Fundamental
  • Price
  • PT $0.95
  • RLYB $0.48
  • Analyst Decision
  • PT
  • RLYB Hold
  • Analyst Count
  • PT 0
  • RLYB 3
  • Target Price
  • PT N/A
  • RLYB $15.00
  • AVG Volume (30 Days)
  • PT 20.7K
  • RLYB 8.4M
  • Earning Date
  • PT 08-05-2025
  • RLYB 08-07-2025
  • Dividend Yield
  • PT N/A
  • RLYB N/A
  • EPS Growth
  • PT N/A
  • RLYB N/A
  • EPS
  • PT N/A
  • RLYB N/A
  • Revenue
  • PT $4,814,566.00
  • RLYB $848,000.00
  • Revenue This Year
  • PT N/A
  • RLYB N/A
  • Revenue Next Year
  • PT N/A
  • RLYB N/A
  • P/E Ratio
  • PT N/A
  • RLYB N/A
  • Revenue Growth
  • PT N/A
  • RLYB N/A
  • 52 Week Low
  • PT $0.76
  • RLYB $0.22
  • 52 Week High
  • PT $1.15
  • RLYB $1.54
  • Technical
  • Relative Strength Index (RSI)
  • PT 49.77
  • RLYB 57.32
  • Support Level
  • PT $0.90
  • RLYB $0.42
  • Resistance Level
  • PT $0.96
  • RLYB $0.53
  • Average True Range (ATR)
  • PT 0.07
  • RLYB 0.05
  • MACD
  • PT -0.01
  • RLYB 0.00
  • Stochastic Oscillator
  • PT 47.78
  • RLYB 68.57

About PT Pintec Technology Holdings Limited

Pintec Technology Holdings Ltd is a technology platform that provides financial services in China in terms of loan volume facilitated. The company connects business partners and financial partners on its open platform and enables them to provide financial services to end-users. Its products include installment loans, personal loans, wealth management, insurance brokerage, SME loans, and others. The company generates its revenue from technical service fees, as well as by providing financing for these borrowers and earning installment service fees. The company earns wealth management services fees and commissions on financial products. The company generates the majority of its revenue from Wealth management service fees and others.

About RLYB Rallybio Corporation

Rallybio Corp is a clinical stage biotechnology company committed to identifying and accelerating the development of life-transforming therapies for patients with severe and rare disorders. The programs of the company are for the prevention of fetal and neonatal alloimmune thrombocytopenia, a potentially life-threatening rare disease that can cause uncontrolled bleeding in fetuses and newborns.

Share on Social Networks: